_id
6915f9fabc934aba376b268e
Ticker
SLDB
Name
Solid Biosciences LLC
Exchange
NASDAQ
Address
500 Rutherford Avenue, Charlestown, MA, United States, 02129
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.solidbio.com
Description
Solid Biosciences Inc. develops therapies for neuromuscular and cardiac diseases in the United States. The company's lead product candidate is SGT-003, which is in phase 1/2 for the treatment of Duchenne muscular dystrophy. It also develops SGT-212 for the treatment of Friedreich's ataxia that is in phase 1b clinical trial; SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia that is in preclinical phase; SGT-601 the treatment of TNNT2-mediated dilated cardiomyopathy, which is in preclinical phase; SGT-401 for the treatment of BAG3-mediated dilated cardiomyopathy that is in preclinical phase; SGT-701 for treatment of rare inherited disease characterized by mutations in the RBM20 gene, which is in discovery phase; and other drugs for the treatment of cardiac and other diseases. In addition, the company is involved in developing platform technologies, including capsid libraries; genetic regulators, such as promoters, UTRs, and introns; immunomodulation technologies; manufacturing purity; and dual gene expression, a technology for packaging multiple transgenes into one capsid. The company has collaboration and license agreement with Ultragenyx Pharmaceutical Inc.; and a license agreement with the University of Washington, University of Missouri, University of Florida, and ICS Maugeri S.p.A. Solid Biosciences Inc. was incorporated in 2013 and is headquartered in Charlestown, Massachusetts.
Last Close
5.87
Volume
711968
Current Price
5.87
Change
0
Last Updated
2025-12-04T13:08:29.377Z
Image
data:image/webp;base64,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
Ipo Date
2018-01-26T00:00:00.000Z
Market Cap
404354144
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9922000000000001
Sentiment Sources
5
Rating
4.5833
Target Price
15.1667
Strong Buy
7
Buy
5
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
376000
Gross Profit
-376000
Operating Expenses
48058000
Operating Income
-48058000
Interest Expense
336000
Pretax Income
-45776000
Net Income
-45776000
Eps
-0.48482411346697474
Dividends Per Share
-
Shares Outstanding
77910239
Income Tax Expense
-
EBITDA
-45400000
Operating Margin
-
Total Other Income Expense Net
2282000
Cash
61364000
Short Term Investments
174778000
Receivables
-
Inventories
-
Total Current Assets
244852000
Property Plant Equipment
26891000
Total Assets
273914000
Payables
8429000
Short Term Debt
2313000
Long Term Debt
-
Total Liabilities
55966000
Equity
217948000
Depreciation
-1046000
Change In Working Capital
7173000
Cash From Operations
-33472000
Capital Expenditures
85000
Cash From Investing
-45273000
Cash From Financing
1176000
Net Change In Cash
-77569000
PE
-
PB
2.542955975829097
ROE
-21.00317506928258
ROA
-16.711814657155166
FCF
-33557000
Fcf Percent
-
Piotroski FScore
1
Health Score
43
Deep Value Investing Score
3.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2
Net Net Investing Score
2.5
Quality Investing Score
2.5
Value Investing Score
4
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
376000
Quarters > 0 > income Statement > gross Profit
-376000
Quarters > 0 > income Statement > operating Expenses
48058000
Quarters > 0 > income Statement > operating Income
-48058000
Quarters > 0 > income Statement > interest Expense
336000
Quarters > 0 > income Statement > pretax Income
-45776000
Quarters > 0 > income Statement > net Income
-45776000
Quarters > 0 > income Statement > eps
-0.48482411346697474
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
94417746
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-45400000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
2282000
Quarters > 0 > balance Sheet > cash
61364000
Quarters > 0 > balance Sheet > short Term Investments
174778000
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
244852000
Quarters > 0 > balance Sheet > property Plant Equipment
26891000
Quarters > 0 > balance Sheet > total Assets
273914000
Quarters > 0 > balance Sheet > payables
8429000
Quarters > 0 > balance Sheet > short Term Debt
2313000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
55966000
Quarters > 0 > balance Sheet > equity
217948000
Quarters > 0 > cash Flow > net Income
-45776000
Quarters > 0 > cash Flow > depreciation
-1046000
Quarters > 0 > cash Flow > change In Working Capital
7173000
Quarters > 0 > cash Flow > cash From Operations
-33472000
Quarters > 0 > cash Flow > capital Expenditures
85000
Quarters > 0 > cash Flow > cash From Investing
-45273000
Quarters > 0 > cash Flow > cash From Financing
1176000
Quarters > 0 > cash Flow > net Change In Cash
-77569000
Quarters > 0 > ratios > PE
-0.48482411346697474
Quarters > 0 > ratios > PB
2.542955975829097
Quarters > 0 > ratios > ROE
-21.00317506928258
Quarters > 0 > ratios > ROA
-16.711814657155166
Quarters > 0 > ratios > FCF
-33557000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
43
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
386000
Quarters > 1 > income Statement > gross Profit
-386000
Quarters > 1 > income Statement > operating Expenses
41307000
Quarters > 1 > income Statement > operating Income
-41693000
Quarters > 1 > income Statement > interest Expense
60000
Quarters > 1 > income Statement > pretax Income
-39480000
Quarters > 1 > income Statement > net Income
-39480000
Quarters > 1 > income Statement > eps
-0.4193741242723652
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
94140286
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-39034000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
2213000
Quarters > 1 > balance Sheet > cash
138933000
Quarters > 1 > balance Sheet > short Term Investments
129177000
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
278640000
Quarters > 1 > balance Sheet > property Plant Equipment
27450000
Quarters > 1 > balance Sheet > total Assets
308292000
Quarters > 1 > balance Sheet > payables
4704000
Quarters > 1 > balance Sheet > short Term Debt
2896000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
50001000
Quarters > 1 > balance Sheet > equity
258291000
Quarters > 1 > cash Flow > net Income
-39480000
Quarters > 1 > cash Flow > depreciation
-488000
Quarters > 1 > cash Flow > change In Working Capital
-2539000
Quarters > 1 > cash Flow > cash From Operations
-37412000
Quarters > 1 > cash Flow > capital Expenditures
377000
Quarters > 1 > cash Flow > cash From Investing
-32732000
Quarters > 1 > cash Flow > cash From Financing
-1601000
Quarters > 1 > cash Flow > net Change In Cash
-71745000
Quarters > 1 > ratios > PE
-0.4193741242723652
Quarters > 1 > ratios > PB
2.139460836111208
Quarters > 1 > ratios > ROE
-15.285085426902215
Quarters > 1 > ratios > ROA
-12.806041026040246
Quarters > 1 > ratios > FCF
-37789000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
43
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
407000
Quarters > 2 > income Statement > gross Profit
-407000
Quarters > 2 > income Statement > operating Expenses
39645000
Quarters > 2 > income Statement > operating Income
-40052000
Quarters > 2 > income Statement > interest Expense
68000
Quarters > 2 > income Statement > pretax Income
-39282000
Quarters > 2 > income Statement > net Income
-39282000
Quarters > 2 > income Statement > eps
-0.5921197962566458
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
66341305
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-38807000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
770000
Quarters > 2 > balance Sheet > cash
210629000
Quarters > 2 > balance Sheet > short Term Investments
96289000
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
313409000
Quarters > 2 > balance Sheet > property Plant Equipment
28203000
Quarters > 2 > balance Sheet > total Assets
343904000
Quarters > 2 > balance Sheet > payables
6439000
Quarters > 2 > balance Sheet > short Term Debt
2964000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
49441000
Quarters > 2 > balance Sheet > equity
294463000
Quarters > 2 > cash Flow > net Income
-39282000
Quarters > 2 > cash Flow > depreciation
407000
Quarters > 2 > cash Flow > change In Working Capital
1793000
Quarters > 2 > cash Flow > cash From Operations
-31850000
Quarters > 2 > cash Flow > capital Expenditures
126000
Quarters > 2 > cash Flow > cash From Investing
-27463000
Quarters > 2 > cash Flow > cash From Financing
189728000
Quarters > 2 > cash Flow > net Change In Cash
130415000
Quarters > 2 > ratios > PE
-0.5921197962566458
Quarters > 2 > ratios > PB
1.3224869010707627
Quarters > 2 > ratios > ROE
-13.340215918468534
Quarters > 2 > ratios > ROA
-11.422373685679725
Quarters > 2 > ratios > FCF
-31976000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
43
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
3124000
Quarters > 3 > income Statement > cost Of Revenue
488000
Quarters > 3 > income Statement > gross Profit
-488000
Quarters > 3 > income Statement > operating Expenses
39896000
Quarters > 3 > income Statement > operating Income
-39896000
Quarters > 3 > income Statement > interest Expense
75000
Quarters > 3 > income Statement > pretax Income
-42597000
Quarters > 3 > income Statement > net Income
-42597000
Quarters > 3 > income Statement > eps
-0.7950293652458448
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
53579153
Quarters > 3 > income Statement > income Tax Expense
951276
Quarters > 3 > income Statement > EBITDA
-42034000
Quarters > 3 > income Statement > operating Margin
-1277.08066581306
Quarters > 3 > income Statement > total Other Income Expense Net
-2701000
Quarters > 3 > balance Sheet > cash
80235000
Quarters > 3 > balance Sheet > short Term Investments
68685000
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
157302000
Quarters > 3 > balance Sheet > property Plant Equipment
29042000
Quarters > 3 > balance Sheet > total Assets
188662000
Quarters > 3 > balance Sheet > payables
4237000
Quarters > 3 > balance Sheet > short Term Debt
3018000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
51416000
Quarters > 3 > balance Sheet > equity
137246000
Quarters > 3 > cash Flow > net Income
-42597000
Quarters > 3 > cash Flow > depreciation
488000
Quarters > 3 > cash Flow > change In Working Capital
2129000
Quarters > 3 > cash Flow > cash From Operations
-29645000
Quarters > 3 > cash Flow > capital Expenditures
204000
Quarters > 3 > cash Flow > cash From Investing
38567000
Quarters > 3 > cash Flow > cash From Financing
6940000
Quarters > 3 > cash Flow > net Change In Cash
15862000
Quarters > 3 > ratios > PE
-0.7950293652458448
Quarters > 3 > ratios > PB
2.2915759155822393
Quarters > 3 > ratios > ROE
-31.036970112061553
Quarters > 3 > ratios > ROA
-22.578473672493665
Quarters > 3 > ratios > FCF
-29849000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-9.554737516005122
Quarters > 3 > health Score
35
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
2455000
Annuals > 0 > income Statement > gross Profit
-2455000
Annuals > 0 > income Statement > operating Expenses
127273000
Annuals > 0 > income Statement > operating Income
-129728000
Annuals > 0 > income Statement > interest Expense
340000
Annuals > 0 > income Statement > pretax Income
-124697000
Annuals > 0 > income Statement > net Income
-124697000
Annuals > 0 > income Statement > eps
-3.0550260920694807
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
40817000
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-121902000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
5031000
Annuals > 0 > balance Sheet > cash
80235000
Annuals > 0 > balance Sheet > short Term Investments
68685000
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
157302000
Annuals > 0 > balance Sheet > property Plant Equipment
29042000
Annuals > 0 > balance Sheet > total Assets
188662000
Annuals > 0 > balance Sheet > payables
4237000
Annuals > 0 > balance Sheet > short Term Debt
3018000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
51416000
Annuals > 0 > balance Sheet > equity
137246000
Annuals > 0 > cash Flow > net Income
-124697000
Annuals > 0 > cash Flow > depreciation
2455000
Annuals > 0 > cash Flow > change In Working Capital
2850000
Annuals > 0 > cash Flow > cash From Operations
-100012000
Annuals > 0 > cash Flow > capital Expenditures
654000
Annuals > 0 > cash Flow > cash From Investing
-16086000
Annuals > 0 > cash Flow > cash From Financing
122437000
Annuals > 0 > cash Flow > net Change In Cash
6339000
Annuals > 0 > ratios > PE
-3.0550260920694807
Annuals > 0 > ratios > PB
1.5435074974862655
Annuals > 0 > ratios > ROE
-90.85656412573044
Annuals > 0 > ratios > ROA
-66.09545112423275
Annuals > 0 > ratios > FCF
-100666000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
2581000
Annuals > 1 > income Statement > gross Profit
-2581000
Annuals > 1 > income Statement > operating Expenses
101734000
Annuals > 1 > income Statement > operating Income
-104315000
Annuals > 1 > income Statement > interest Expense
440000
Annuals > 1 > income Statement > pretax Income
-96015000
Annuals > 1 > income Statement > net Income
-96015000
Annuals > 1 > income Statement > eps
-4.828756789378395
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
19884000
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-93434000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
8300000
Annuals > 1 > balance Sheet > cash
74015000
Annuals > 1 > balance Sheet > short Term Investments
49625000
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
129734000
Annuals > 1 > balance Sheet > property Plant Equipment
33163000
Annuals > 1 > balance Sheet > total Assets
164939000
Annuals > 1 > balance Sheet > payables
2032000
Annuals > 1 > balance Sheet > short Term Debt
2324000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
38458000
Annuals > 1 > balance Sheet > equity
126481000
Annuals > 1 > cash Flow > net Income
-96015000
Annuals > 1 > cash Flow > depreciation
2581000
Annuals > 1 > cash Flow > change In Working Capital
-6337000
Annuals > 1 > cash Flow > cash From Operations
-94180000
Annuals > 1 > cash Flow > capital Expenditures
1515000
Annuals > 1 > cash Flow > cash From Investing
9689000
Annuals > 1 > cash Flow > cash From Financing
3122000
Annuals > 1 > cash Flow > net Change In Cash
-81369000
Annuals > 1 > ratios > PE
-4.828756789378395
Annuals > 1 > ratios > PB
0.8159166989508306
Annuals > 1 > ratios > ROE
-75.91258766138787
Annuals > 1 > ratios > ROA
-58.212430049897236
Annuals > 1 > ratios > FCF
-95695000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
33
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
8094000
Annuals > 2 > income Statement > cost Of Revenue
2408000
Annuals > 2 > income Statement > gross Profit
8094000
Annuals > 2 > income Statement > operating Expenses
114546000
Annuals > 2 > income Statement > operating Income
-106452000
Annuals > 2 > income Statement > interest Expense
20471000
Annuals > 2 > income Statement > pretax Income
-85981000
Annuals > 2 > income Statement > net Income
-85981000
Annuals > 2 > income Statement > eps
-10.101045701002421
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
8512089
Annuals > 2 > income Statement > income Tax Expense
-20471000
Annuals > 2 > income Statement > EBITDA
-96866000
Annuals > 2 > income Statement > operating Margin
-1315.196441808747
Annuals > 2 > income Statement > total Other Income Expense Net
20471000
Annuals > 2 > balance Sheet > cash
155384000
Annuals > 2 > balance Sheet > short Term Investments
58338000
Annuals > 2 > balance Sheet > receivables
0
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
219638000
Annuals > 2 > balance Sheet > property Plant Equipment
38606000
Annuals > 2 > balance Sheet > total Assets
260252000
Annuals > 2 > balance Sheet > payables
3238000
Annuals > 2 > balance Sheet > short Term Debt
2565000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
48586000
Annuals > 2 > balance Sheet > equity
211666000
Annuals > 2 > cash Flow > net Income
-85981000
Annuals > 2 > cash Flow > depreciation
2408000
Annuals > 2 > cash Flow > change In Working Capital
-3689000
Annuals > 2 > cash Flow > cash From Operations
-97977000
Annuals > 2 > cash Flow > capital Expenditures
3015000
Annuals > 2 > cash Flow > cash From Investing
59157000
Annuals > 2 > cash Flow > cash From Financing
74831000
Annuals > 2 > cash Flow > net Change In Cash
36011000
Annuals > 2 > ratios > PE
-10.101045701002421
Annuals > 2 > ratios > PB
0.20871439867527145
Annuals > 2 > ratios > ROE
-40.6210728222766
Annuals > 2 > ratios > ROA
-33.03759433164778
Annuals > 2 > ratios > FCF
-100992000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-12.477390659747961
Annuals > 2 > health Score
34
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
13620000
Annuals > 3 > income Statement > cost Of Revenue
2964000
Annuals > 3 > income Statement > gross Profit
13620000
Annuals > 3 > income Statement > operating Expenses
85874000
Annuals > 3 > income Statement > operating Income
-72254000
Annuals > 3 > income Statement > interest Expense
66000
Annuals > 3 > income Statement > pretax Income
-72188000
Annuals > 3 > income Statement > net Income
-72188000
Annuals > 3 > income Statement > eps
-10.141578617886088
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
7118024
Annuals > 3 > income Statement > income Tax Expense
-64000
Annuals > 3 > income Statement > EBITDA
-69290000
Annuals > 3 > income Statement > operating Margin
-530.4992657856094
Annuals > 3 > income Statement > total Other Income Expense Net
66000
Annuals > 3 > balance Sheet > cash
119136000
Annuals > 3 > balance Sheet > short Term Investments
88643000
Annuals > 3 > balance Sheet > receivables
110000
Annuals > 3 > balance Sheet > inventories
6015000
Annuals > 3 > balance Sheet > total Current Assets
222612000
Annuals > 3 > balance Sheet > property Plant Equipment
7604000
Annuals > 3 > balance Sheet > total Assets
232380000
Annuals > 3 > balance Sheet > payables
4463000
Annuals > 3 > balance Sheet > short Term Debt
1495000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
24169000
Annuals > 3 > balance Sheet > equity
208211000
Annuals > 3 > cash Flow > net Income
-72188000
Annuals > 3 > cash Flow > depreciation
2964000
Annuals > 3 > cash Flow > change In Working Capital
-23041000
Annuals > 3 > cash Flow > cash From Operations
-77764000
Annuals > 3 > cash Flow > capital Expenditures
1281000
Annuals > 3 > cash Flow > cash From Investing
-91086000
Annuals > 3 > cash Flow > cash From Financing
134985000
Annuals > 3 > cash Flow > net Change In Cash
-33865000
Annuals > 3 > ratios > PE
-10.141578617886088
Annuals > 3 > ratios > PB
0.17742839984438866
Annuals > 3 > ratios > ROE
-34.670598575483524
Annuals > 3 > ratios > ROA
-31.064635510801274
Annuals > 3 > ratios > FCF
-79045000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-5.80359765051395
Annuals > 3 > health Score
34
Valuation > metrics > PE
-0.48482411346697474
Valuation > metrics > PB
2.542955975829097
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-21.00317506928258
Profitability > metrics > ROA
-18.69537516540604
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.256786022353956
Risk > metrics > Interest Coverage
-143.0297619047619
Risk > final Score
-512
Risk > verdict
High
Liquidity > metrics > Current Ratio
22.793893129770993
Liquidity > metrics > Quick Ratio
22.793893129770993
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
80
Prev Valuations > 2
80
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
0
Prev Risks > 0
-2720
Prev Risks > 1
-2296
Prev Risks > 2
-2068
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T01:11:40.729Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-04
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.48
Earnings History > 0 > eps Estimate
-0.4407
Earnings History > 0 > eps Difference
-0.0393
Earnings History > 0 > surprise Percent
-8.9176
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-12
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.42
Earnings History > 1 > eps Estimate
-0.64
Earnings History > 1 > eps Difference
0.22
Earnings History > 1 > surprise Percent
34.375
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-13
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.59
Earnings History > 2 > eps Estimate
-0.541
Earnings History > 2 > eps Difference
-0.049
Earnings History > 2 > surprise Percent
-9.0573
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-11
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-1
Earnings History > 3 > eps Estimate
-0.7822
Earnings History > 3 > eps Difference
-0.2178
Earnings History > 3 > surprise Percent
-27.8445
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-06
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.79
Earnings History > 4 > eps Estimate
-0.67
Earnings History > 4 > eps Difference
-0.12
Earnings History > 4 > surprise Percent
-17.9104
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-13
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.61
Earnings History > 5 > eps Estimate
-0.65
Earnings History > 5 > eps Difference
0.04
Earnings History > 5 > surprise Percent
6.1538
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-15
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.64
Earnings History > 6 > eps Estimate
-0.64
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
0
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-13
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-1
Earnings History > 7 > eps Estimate
-0.99
Earnings History > 7 > eps Difference
-0.01
Earnings History > 7 > surprise Percent
-1.0101
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-08
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-1.05
Earnings History > 8 > eps Estimate
-1.19
Earnings History > 8 > eps Difference
0.14
Earnings History > 8 > surprise Percent
11.7647
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-14
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-1.25
Earnings History > 9 > eps Estimate
-1.53
Earnings History > 9 > eps Difference
0.28
Earnings History > 9 > surprise Percent
18.3007
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-11
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-1.5
Earnings History > 10 > eps Estimate
-2.05
Earnings History > 10 > eps Difference
0.55
Earnings History > 10 > surprise Percent
26.8293
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-23
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.68
Earnings History > 11 > eps Estimate
-1.65
Earnings History > 11 > eps Difference
0.97
Earnings History > 11 > surprise Percent
58.7879
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-10
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-2.71
Earnings History > 12 > eps Estimate
-2.67
Earnings History > 12 > eps Difference
-0.04
Earnings History > 12 > surprise Percent
-1.4981
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-11
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-3.3
Earnings History > 13 > eps Estimate
-3.15
Earnings History > 13 > eps Difference
-0.15
Earnings History > 13 > surprise Percent
-4.7619
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-04-27
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-3.3
Earnings History > 14 > eps Estimate
-2.76
Earnings History > 14 > eps Difference
-0.54
Earnings History > 14 > surprise Percent
-19.5652
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-14
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-2.4
Earnings History > 15 > eps Estimate
-2.91
Earnings History > 15 > eps Difference
0.51
Earnings History > 15 > surprise Percent
17.5258
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-03
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-2.4
Earnings History > 16 > eps Estimate
-3.02
Earnings History > 16 > eps Difference
0.62
Earnings History > 16 > surprise Percent
20.5298
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-16
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-2.55
Earnings History > 17 > eps Estimate
-2.82
Earnings History > 17 > eps Difference
0.27
Earnings History > 17 > surprise Percent
9.5745
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-14
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
BeforeMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-2.85
Earnings History > 18 > eps Estimate
-4.86
Earnings History > 18 > eps Difference
2.01
Earnings History > 18 > surprise Percent
41.358
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-15
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-4.65
Earnings History > 19 > eps Estimate
-5.09
Earnings History > 19 > eps Difference
0.44
Earnings History > 19 > surprise Percent
8.6444
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-11-05
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
BeforeMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-6.6
Earnings History > 20 > eps Estimate
-5.17
Earnings History > 20 > eps Difference
-1.43
Earnings History > 20 > surprise Percent
-27.6596
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-08-06
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
BeforeMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-5.85
Earnings History > 21 > eps Estimate
-7.45
Earnings History > 21 > eps Difference
1.6
Earnings History > 21 > surprise Percent
21.4765
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-05-07
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
BeforeMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-7.65
Earnings History > 22 > eps Estimate
-7.83
Earnings History > 22 > eps Difference
0.18
Earnings History > 22 > surprise Percent
2.2989
Earnings History > 23 > period
2019-12-31
Earnings History > 23 > report Date
2020-03-12
Earnings History > 23 > date
2019-12-31
Earnings History > 23 > before After Market
BeforeMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-9.75
Earnings History > 23 > eps Estimate
-9.14
Earnings History > 23 > eps Difference
-0.61
Earnings History > 23 > surprise Percent
-6.674
Earnings History > 24 > period
2019-09-30
Earnings History > 24 > report Date
2019-11-12
Earnings History > 24 > date
2019-09-30
Earnings History > 24 > before After Market
BeforeMarket
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-10.05
Earnings History > 24 > eps Estimate
-9.65
Earnings History > 24 > eps Difference
-0.4
Earnings History > 24 > surprise Percent
-4.1451
Earnings History > 25 > period
2019-06-30
Earnings History > 25 > report Date
2019-08-14
Earnings History > 25 > date
2019-06-30
Earnings History > 25 > before After Market
BeforeMarket
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-11.4
Earnings History > 25 > eps Estimate
-11.81
Earnings History > 25 > eps Difference
0.41
Earnings History > 25 > surprise Percent
3.4716
Earnings History > 26 > period
2019-03-31
Earnings History > 26 > report Date
2019-05-13
Earnings History > 26 > date
2019-03-31
Earnings History > 26 > before After Market
AfterMarket
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-12.75
Earnings History > 26 > eps Estimate
-9.48
Earnings History > 26 > eps Difference
-3.27
Earnings History > 26 > surprise Percent
-34.4937
Earnings History > 27 > period
2018-12-31
Earnings History > 27 > report Date
2019-03-13
Earnings History > 27 > date
2018-12-31
Earnings History > 27 > before After Market
BeforeMarket
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
-9.49
Earnings History > 27 > eps Estimate
-9.09
Earnings History > 27 > eps Difference
-0.4
Earnings History > 27 > surprise Percent
-4.4004
Earnings History > 28 > period
2018-09-30
Earnings History > 28 > report Date
2018-11-13
Earnings History > 28 > date
2018-09-30
Earnings History > 28 > before After Market
BeforeMarket
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
-8.25
Earnings History > 28 > eps Estimate
-8.4
Earnings History > 28 > eps Difference
0.15
Earnings History > 28 > surprise Percent
1.7857
Earnings History > 29 > period
2018-06-30
Earnings History > 29 > report Date
2018-08-10
Earnings History > 29 > date
2018-06-30
Earnings History > 29 > before After Market
BeforeMarket
Earnings History > 29 > currency
USD
Earnings History > 29 > eps Actual
-7.8
Earnings History > 29 > eps Estimate
-7.65
Earnings History > 29 > eps Difference
-0.15
Earnings History > 29 > surprise Percent
-1.9608
Earnings History > 30 > period
2018-03-31
Earnings History > 30 > report Date
2018-05-10
Earnings History > 30 > date
2018-03-31
Earnings History > 30 > before After Market
BeforeMarket
Earnings History > 30 > currency
USD
Earnings History > 30 > eps Actual
-8.1
Earnings History > 30 > eps Estimate
-6.8
Earnings History > 30 > eps Difference
-1.3
Earnings History > 30 > surprise Percent
-19.1176
Earnings History > 31 > period
2017-12-31
Earnings History > 31 > report Date
2018-03-29
Earnings History > 31 > date
2017-12-31
Earnings History > 31 > before After Market
BeforeMarket
Earnings History > 31 > currency
USD
Earnings History > 31 > eps Actual
-13.35
Earnings History > 31 > eps Estimate
-8.95
Earnings History > 31 > eps Difference
-4.4
Earnings History > 31 > surprise Percent
-49.162
Earnings History > 32 > period
2017-09-30
Earnings History > 32 > report Date
2017-10-23
Earnings History > 32 > date
2017-09-30
Earnings History > 32 > before After Market
-
Earnings History > 32 > currency
USD
Earnings History > 32 > eps Actual
-0.52
Earnings History > 32 > eps Estimate
0
Earnings History > 32 > eps Difference
-0.52
Earnings History > 32 > surprise Percent
-
Earnings History > 33 > period
2016-12-31
Earnings History > 33 > report Date
2017-02-03
Earnings History > 33 > date
2016-12-31
Earnings History > 33 > before After Market
-
Earnings History > 33 > currency
USD
Earnings History > 33 > eps Actual
-0.14
Earnings History > 33 > eps Estimate
0
Earnings History > 33 > eps Difference
-0.14
Earnings History > 33 > surprise Percent
-
Solid Biosciences Inc. develops therapies for neuromuscular and cardiac diseases in the United States. The company's lead product candidate is SGT-003, which is in phase 1/2 for the treatment of Duchenne muscular dystrophy. It also develops SGT-212 for the treatment of Friedreich's ataxia that is in phase 1b clinical trial; SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia that is in preclinical phase; SGT-601 the treatment of TNNT2-mediated dilated cardiomyopathy, which is in preclinical phase; SGT-401 for the treatment of BAG3-mediated dilated cardiomyopathy that is in preclinical phase; SGT-701 for treatment of rare inherited disease characterized by mutations in the RBM20 gene, which is in discovery phase; and other drugs for the treatment of cardiac and other diseases. In addition, the company is involved in developing platform technologies, including capsid libraries; genetic regulators, such as promoters, UTRs, and introns; immunomodulation technologies; manufacturing purity; and dual gene expression, a technology for packaging multiple transgenes into one capsid. The company has collaboration and license agreement with Ultragenyx Pharmaceutical Inc.; and a license agreement with the University of Washington, University of Missouri, University of Florida, and ICS Maugeri S.p.A. Solid Biosciences Inc. was incorporated in 2013 and is headquartered in Charlestown, Massachusetts.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ASolid Biosciences Inc. (NASDAQ:SLDB) Given Average Recommendation of “Moderate Buy” by Brokerages Defense World
Read more →Solid Biosciences (NASDAQ:SLDB) Research Coverage Started at Needham & Company LLC - Defense World
12/7/2025
Solid Biosciences (NASDAQ:SLDB) Research Coverage Started at Needham & Company LLC Defense World
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$15.1667
Analyst Picks
Strong Buy
7
Buy
5
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 107.23% of the total shares of Solid Biosciences LLC
1.
Perceptive Advisors LLC(15.2906%)
since
2025/06/30
2.
Bain Capital Life Sciences Investors, LLC(10.1602%)
since
2025/06/30
3.
Siren, L.L.C.(9.5236%)
since
2025/06/30
4.
Adage Capital Partners Gp LLC(8.642%)
since
2025/06/30
5.
RA Capital Management, LLC(7.4629%)
since
2025/06/30
6.
BlackRock Inc(6.3184%)
since
2025/06/30
7.
Vanguard Group Inc(4.3221%)
since
2025/06/30
8.
FMR Inc(4.0817%)
since
2025/06/30
9.
Fidelity Select Biotechnology(3.6828%)
since
2025/07/31
10.
Citadel Advisors Llc(3.2404%)
since
2025/06/30
11.
Monashee Investment Management LLC(2.7803%)
since
2025/06/30
12.
Redmile Group, LLC(2.4604%)
since
2025/06/30
13.
Vanguard Total Stock Mkt Idx Inv(2.3992%)
since
2025/07/31
14.
Nantahala Capital Management, LLC(2.1874%)
since
2025/06/30
15.
Alyeska Investment Group, L.P.(2.1072%)
since
2025/06/30
16.
MPM Oncology Impact Management LP(2.0991%)
since
2025/06/30
17.
Franklin Resources Inc(2.0537%)
since
2025/06/30
18.
iShares Russell 2000 ETF(2.0339%)
since
2025/08/31
19.
Geode Capital Management, LLC(1.9393%)
since
2025/06/30
20.
Vestal Point Capital LP(1.9327%)
since
2025/06/30
21.
Point72 Asset Management, L.P.(1.6259%)
since
2025/06/30
22.
Millennium Management LLC(1.4118%)
since
2025/06/30
23.
Franklin Biotechnology Discv A(acc)USD(1.3256%)
since
2025/08/31
24.
Finepoint Capital LP(1.2344%)
since
2025/06/30
25.
Fidelity Small Cap Index(0.8518%)
since
2025/06/30
26.
Vanguard Institutional Extnd Mkt Idx Tr(0.8253%)
since
2025/07/31
27.
International Biotechnology Ord(0.7474%)
since
2025/07/31
28.
iShares Russell 2000 Value ETF(0.7353%)
since
2025/08/31
29.
Franklin Biotechnology Discovery A(0.7278%)
since
2025/07/31
30.
iShares Biotechnology ETF(0.4293%)
since
2025/08/31
31.
Fidelity Extended Market Index(0.4115%)
since
2025/07/31
32.
Vanguard Russell 2000 ETF(0.4042%)
since
2025/07/31
33.
Nuveen Equity Index R6(0.3968%)
since
2025/07/31
34.
State St Russell Sm Cap® Indx SL Cl I(0.2991%)
since
2025/08/31
35.
Schwab Small Cap Index(0.213%)
since
2025/07/31
36.
NT R2000 Index Fund - NL(0.2051%)
since
2025/06/30
37.
iShares Micro-Cap ETF(0.1929%)
since
2025/08/31
38.
NT R2000 Index Fund - DC - NL - 3(0.1636%)
since
2025/06/30
39.
Extended Equity Market Fund K(0.1611%)
since
2025/06/30
40.
Fidelity Total Market Index(0.1547%)
since
2025/07/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.48
EPS Estimate
-0.4407
EPS Difference
-0.0393
Surprise Percent
-8.9176%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.